Summary

Neurodegeneration refers to the progressive loss of neuron structure or function, which may eventually lead to cell death. Many neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease and prion disease, are the results of neurodegenerative processes. Neurodegeneration can be found in many different levels of neuronal circuits in the brain, from molecules to systems. Since there is no known method to reverse the progressive degeneration of neurons, these diseases are considered incurable. Biomedical research has revealed many similarities between these diseases at the subcellular level, including atypical protein assembly (such as protein diseases) and induction of cell death. These similarities indicate that progress in the treatment of one neurodegenerative disease may also improve other diseases. This collection of entries aims to collect various medical research results related to neurodegeneration. We invite researchers to share their new results and ideas related to neurodegeneration.

Expand All
Entries
Topic Review
Picein
Picein is a herbal agent that has been investigated in only a few studies. Picein is the active ingredient of several herbs and can thus be extracted from different types of plants, which renders it widely available. To date, picein has shown to exhibit antioxidant and anti-inflammatory properties in cellular and plant studies.
  • 646
  • 31 Oct 2022
Topic Review
Diagnosis and Assessment of Degenerative Cervical Myelopathy
Degenerative cervical myelopathy (DCM) manifests as the primary cause of spinal cord dysfunction and is non-traumatic, chronic and progressive in nature. Decompressive surgery is typically utilised to halt further disability and neurological dysfunction and as such, early diagnosis and assessment is a vital means of slowing the disease process. Currently, there exists a plethora of methods for diagnosing DCM, each with their own unique limitations. The limitations of current diagnostic techniques and some novel quantitative MRI (qMRI) techniques for assessing spinal cord integrity in DCM were described here.
  • 595
  • 28 Oct 2022
Topic Review
Epigenetic Changes and Chromatin Reorganization in Brain Function
Healthy brain functioning in mammals requires a continuous fine-tuning of gene expression. Accumulating evidence over the past demonstrates that epigenetic mechanisms and dynamic changes in chromatin organization are critical components during the control of gene transcription in neural cells. Genome-wide analyses show that the regulation of brain genes requires the contribution of both promoter and long-distance enhancer elements, which must functionally interact to upregulate gene expression in response to physiological cues. Hence, a deep comprehension of the mechanisms mediating these enhancer–promoter interactions (EPIs) is critical if people are to understand the processes associated with learning, memory and recall. Moreover, the onset and progression of several neurodegenerative diseases and neurological alterations are found to be strongly associated with changes in the components that support and/or modulate the dynamics of these EPIs. 
  • 406
  • 28 Oct 2022
Topic Review
Cytokine Imbalance in Treatment-Resistant Schizophrenia
Treatment-resistant schizophrenia (TRS) is an important and unresolved problem in biological and clinical psychiatry. Approximately 30% of cases of schizophrenia (Sch) are TRS, which may be due to the fact that some patients with TRS may suffer from pathogenetically “non-dopamine” Sch, in the development of which neuroinflammation is supposed to play an important role. There are many factors leading to a chronic neuroinflammatory process in TRS. 
  • 479
  • 27 Oct 2022
Topic Review
Intestinal Enteroendocrine Cells in Parkinson’s Disease
Intestinal epithelial enteroendocrine cells (EECs) residing in the epithelium throughout intestine are the key regulators orchestrating the communication along the brain-gut-microbiota axis. On one hand, EECs sense changes in luminal microorganisms via microbial metabolites; on the other hand, they communicate with host body systems via neuroendocrine molecules. Therefore, EECs are believed to play important roles in neurological and psychiatric disorders.
  • 810
  • 28 Oct 2022
Topic Review
Effects of Ellagic Acid in Neurological Diseases
Aging is associated with several diseases that threaten the health of older people, such as neurodegenerative diseases, which cause indelible and irreversible damage to both the physical and psychological well-being of older people and impose a heavy burden on their families and society. In recent years, a large number of studies have focused on the therapeutic effects of Ellagic Acid, demonstrating the health benefits of EA for neurodegenerative diseases. Three common neurological diseases are described here: AD, PD, and cerebral ischemia as well as the antioxidative and anti-inflammatory protective effects of EA.
  • 463
  • 26 Oct 2022
Topic Review
Clinical Trials of Pimavanserin
Pimavanserin (PMV) is the first approved drug for treating hallucinations and delusions in Parkinson’s disease (PD) psychosis. Psychosis is one of the leading causes of nursing home placement in people with PD. Furthermore, hallucinations are a more frequent cause of institutionalization than motor disability or dementia related to PD. The management of PD psychosis involves antipsychotic medications. Most of the drugs in this class directly block dopamine D2 receptors, leading to significantly worsening motor symptoms in patients with PD. The most commonly used medications for managing PD psychosis are quetiapine, clozapine, and PMV. 
  • 445
  • 26 Oct 2022
Topic Review
Monitoring the Redox Status in Multiple Sclerosis
Worldwide, over 2.2 million people suffer from multiple sclerosis (MS), a multifactorial demyelinating disease of the central nervous system. MS is characterized by a wide range of motor, autonomic, and psychobehavioral symptoms, including depression, anxiety, and dementia. The blood, cerebrospinal fluid, and postmortem brain samples of MS patients provide evidence on the disturbance of reduction-oxidation (redox) homeostasis, such as the alterations of oxidative and antioxidative enzyme activities and the presence of degradation products. 
  • 526
  • 25 Oct 2022
Topic Review
Kynurenines in Neurodegenerative Diseases
Neurodegenerative diseases are multifactorial, initiated by a series of the causative complex which develops into a certain clinical picture. The pathogenesis and disease course vary from patient to patient. Thus, it should be likewise to the treatment. Peripheral biomarkers are to play a central role for tailoring a personalized therapeutic plan for patients who suffered from neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, among others. Nevertheless, the use of biomarkers in clinical practice is still underappreciated and data presented in biomarker research for clinical use is still uncompelling, compared to the abundant data available for drug research and development. So is the case with kynurenines (KYNs) and the kynurenine pathway (KP) enzymes, which have been associated with a wide range of diseases including cancer, autoimmune diseases, inflammatory diseases, neurologic diseases, and psychiatric disorders. 
  • 552
  • 25 Oct 2022
Topic Review
The Etiological Links behind Neurodegenerative Diseases
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases (NDs), presenting a broad range of symptoms from motor dysfunctions to psychobehavioral manifestations. A common clinical course is the proteinopathy-induced neural dysfunction leading to anatomically corresponding neuropathies. 
  • 590
  • 28 Oct 2022
  • Page
  • of
  • 49

Featured Entry Collections

>>